Literature DB >> 1707186

Crystal structure of the ribonuclease H domain of HIV-1 reverse transcriptase.

J F Davies1, Z Hostomska, Z Hostomsky, S R Jordan, D A Matthews.   

Abstract

The crystal structure of the ribonuclease (RNase) H domain of HIV-1 reverse transcriptase (RT) has been determined at a resolution of 2.4 A and refined to a crystallographic R factor of 0.20. The protein folds into a five-stranded mixed beta sheet flanked by an asymmetric distribution of four alpha helices. Two divalent metal cations bind in the active site surrounded by a cluster of four conserved acidic amino acid residues. The overall structure is similar in most respects to the RNase H from Escherichia coli. Structural features characteristic of the retroviral protein suggest how it may interface with the DNA polymerase domain of p66 in the mature RT heterodimer. These features also offer insights into why the isolated RNase H domain is catalytically inactive but when combined in vitro with the isolated p51 domain of RT RNase H activity can be reconstituted. Surprisingly, the peptide bond cleaved by HIV-1 protease near the polymerase-RNase H junction of p66 is completely inaccessible to solvent in the structure reported here. This suggests that the homodimeric p66-p66 precursor of mature RT is asymmetric with one of the two RNase H domains at least partially unfolded.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1707186     DOI: 10.1126/science.1707186

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  162 in total

1.  Catalytic center of an archaeal type 2 ribonuclease H as revealed by X-ray crystallographic and mutational analyses.

Authors:  A Muroya; D Tsuchiya; M Ishikawa; M Haruki; M Morikawa; S Kanaya; K Morikawa
Journal:  Protein Sci       Date:  2001-04       Impact factor: 6.725

2.  Insertion of a peptide from MuLV RT into the connection subdomain of HIV-1 RT results in a functionally active chimeric enzyme in monomeric conformation.

Authors:  P K Pandey; N Kaushik; T T Talele; P N Yadav; V N Pandey
Journal:  Mol Cell Biochem       Date:  2001-09       Impact factor: 3.396

3.  Replication of phenotypically mixed human immunodeficiency virus type 1 virions containing catalytically active and catalytically inactive reverse transcriptase.

Authors:  J G Julias; A L Ferris; P L Boyer; S H Hughes
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

4.  Expression of Moloney murine leukemia virus RNase H rescues the growth defect of an Escherichia coli mutant.

Authors:  A G Campbell
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

5.  NMR structure of the chimeric hybrid duplex r(gcaguggc).r(gcca)d(CTGC) comprising the tRNA-DNA junction formed during initiation of HIV-1 reverse transcription.

Authors:  T Szyperski; M Götte; M Billeter; E Perola; L Cellai; H Heumann; K Wüthrich
Journal:  J Biomol NMR       Date:  1999-04       Impact factor: 2.835

6.  Dynamic evidence for metal ion catalysis in the reaction mediated by a flap endonuclease.

Authors:  Mark R Tock; Elaine Frary; Jon R Sayers; Jane A Grasby
Journal:  EMBO J       Date:  2003-03-03       Impact factor: 11.598

7.  The p66 immature precursor of HIV-1 reverse transcriptase.

Authors:  Naima G Sharaf; Eric Poliner; Ryan L Slack; Martin T Christen; In-Ja L Byeon; Michael A Parniak; Angela M Gronenborn; Rieko Ishima
Journal:  Proteins       Date:  2014-05-12

8.  Effect of tRNA on the Maturation of HIV-1 Reverse Transcriptase.

Authors:  Tatiana V Ilina; Ryan L Slack; John H Elder; Stefan G Sarafianos; Michael A Parniak; Rieko Ishima
Journal:  J Mol Biol       Date:  2018-05-08       Impact factor: 5.469

9.  Significant expansion of Vicia pannonica genome size mediated by amplification of a single type of giant retroelement.

Authors:  Pavel Neumann; Andrea Koblízková; Alice Navrátilová; Jirí Macas
Journal:  Genetics       Date:  2006-04-03       Impact factor: 4.562

10.  Purification and characterization of an active human immunodeficiency virus type 1 RNase H domain.

Authors:  J S Smith; M J Roth
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.